Quadrature Capital’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-27,020
| Closed | -$12.6M | – | 1590 |
|
|
2025
Q4 | $12.6M | Sell |
27,020
-173,979
| -87% | -$80.8M | 0.13% | 135 |
|
|
2025
Q3 | $85.7M | Buy |
200,999
+182,339
| +977% | +$70.7M | 1.01% | 26 |
|
|
2025
Q2 | $7.15M | Buy |
18,660
+15,738
| +539% | +$5.67M | 0.12% | 141 |
|
|
2025
Q1 | $1.01M | Sell |
2,922
-96,042
| -97% | -$30.9M | 0.02% | 427 |
|
|
2024
Q4 | $29.7M | Buy |
98,964
+81,644
| +471% | +$28.5M | 0.6% | 31 |
|
|
2024
Q3 | $7.04M | Sell |
17,320
-31,184
| -64% | -$11.4M | 0.16% | 112 |
|
|
2024
Q2 | $15.6M | Sell |
48,504
-13,594
| -22% | -$4.42M | 0.26% | 83 |
|
|
2024
Q1 | $20.7M | Buy |
62,098
+35,866
| +137% | +$11M | 0.35% | 64 |
|
|
2023
Q4 | $7.1M | Buy |
26,232
+6,192
| +31% | +$1.53M | 0.13% | 108 |
|
|
2023
Q3 | $4.93M | Buy |
20,040
+9,974
| +99% | +$2.73M | 0.1% | 155 |
|
|
2023
Q2 | $3.05M | Buy |
+10,066
| New | +$2.8M | 0.07% | 228 |
|
|
2022
Q4 | – | Sell |
-53,429
| Closed | -$9.83M | – | 961 |
|
|
2022
Q3 | $9.83M | Sell |
53,429
-79,216
| -60% | -$15.8M | 0.32% | 85 |
|
|
2022
Q2 | $22.3M | Buy |
+132,645
| New | +$28.5M | 0.93% | 17 |
|
|
2022
Q1 | – | Sell |
-2,889
| Closed | -$742K | – | 820 |
|
|
2021
Q4 | $742K | Buy |
+2,889
| New | +$707K | 0.04% | 294 |
|
|
2021
Q2 | – | Sell |
-42,856
| Closed | -$8.07M | – | 1060 |
|
|
2021
Q1 | $8.07M | Buy |
42,856
+40,711
| +1,898% | +$7.18M | 0.39% | 60 |
|
|
2020
Q4 | $353K | Sell |
2,145
-3,545
| -62% | -$518K | 0.02% | 581 |
|
|
2020
Q3 | $710K | Sell |
5,690
-47,757
| -89% | -$5.91M | 0.04% | 420 |
|
|
2020
Q2 | $5.18M | Buy |
53,447
+38,192
| +250% | +$3.97M | 0.59% | 33 |
|
|
2020
Q1 | $1.37M | Sell |
15,255
-41,567
| -73% | -$5.38M | 0.33% | 87 |
|
|
2019
Q4 | $8.4M | Buy |
+56,822
| New | +$7.63M | 0.32% | 96 |
|
|
2019
Q1 | – | Sell |
-16,103
| Closed | -$2M | – | 601 |
|
|
2018
Q4 | $2M | Buy |
+16,103
| New | +$2.16M | 0.37% | 78 |
|
|
2018
Q3 | – | Sell |
-21,526
| Closed | -$2.21M | – | 660 |
|
|
2018
Q2 | $2.21M | Sell |
21,526
-65,145
| -75% | -$6.59M | 0.21% | 123 |
|
|
2018
Q1 | $8.4M | Buy |
+86,671
| New | +$8.41M | 0.65% | 30 |
|
|
2017
Q4 | – | Sell |
-48,506
| Closed | -$3.86M | – | 569 |
|
|
2017
Q3 | $3.86M | Buy |
48,506
+4,090
| +9% | +$329K | 0.48% | 45 |
|
|
2017
Q2 | $3.87M | Sell |
44,416
-120,177
| -73% | -$10.2M | 0.3% | 83 |
|
|
2017
Q1 | $14.6M | Buy |
+164,593
| New | +$13.7M | 1.05% | 14 |
|
|
2016
Q2 | – | Sell |
-25,400
| Closed | -$1.98M | – | 575 |
|
|
2016
Q1 | $1.98M | Sell |
25,400
-148,789
| -85% | -$10.4M | 0.28% | 103 |
|
|
2015
Q4 | $11.8M | Buy |
+174,189
| New | +$12.2M | 1.8% | 5 |
|
|
2015
Q3 | – | Sell |
-11,067
| Closed | -$1M | – | 290 |
|
|
2015
Q2 | $1M | Buy |
+11,067
| New | +$887K | 0.91% | 36 |
|
Other funds holding HCA
Quadrature Capital's HCA Position: Q1 2026 in Review
Quadrature Capital sold out of HCA Healthcare (HCA) in Q1 2026, closing a stake of 27,020 shares — an estimated $12.6M sold.
Quadrature Capital first reported a position in HCA in Q2 2015 and held it in 29 quarters. The position peaked at $85.7M in Q3 2025. 1,420 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Quadrature Capital reported no remaining HCA Healthcare position as of Q1 2026 after selling out during the quarter.
- Quadrature Capital sold 27,020 HCA Healthcare shares in Q1 2026, an estimated $12.6M.
- Quadrature Capital first reported a position in HCA Healthcare in Q2 2015 and held it in 29 quarters.
- Quadrature Capital's HCA Healthcare position peaked at $85.7M in Q3 2025.
- 1,420 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.